Table 1.
Author (Year) | Nation | Age | Sex | BMI Before SG | Previous UGIE | Endoscopic Findings | HP Infection | Smoking | Comorbidity |
---|---|---|---|---|---|---|---|---|---|
Scheepers 201113 | Netherlands | 57 | F | 51.8 | Not | – | – | Yes | OSA, COPD, probably GERD and degenerative joint disease |
Angrisani 201414 | Italy | 51 | F | 61 | Yes | Significant infiltration of plasma cells in the lamina propria | HP- | - | GERD, OSA, hypertension, dyslipidemia |
Erim 201515 | USA | 52 | F | - | Yes | - | - | - | T2DM, hyperlipidemia, hypertension |
Masrur 201616 | USA | 44 | F | 38.2 | Not | - | HP- | Yes | OSA, Hypertension, T1DM, hyperlipidemia |
Sohn 201717 | New Zealand | 44 | F | 42 | Not | - | HP- | Not | OSA, hyperlipidemia |
Vladimirov 201718 | Germany | 47 | F | 47.7 | Yes | Small hiatal hernia and erosive gastritis. | HP- | Yes | COPD |
Wright 201719 | Argentina | 48 | M | 48.5 | Yes | Absence of reflux or hiatal hernia, no esophagitis or Barrett’s esophagus | HP- | - | OSA, hypertension, dyslipidemia, insulin resistance |
EI Khoury 201820 | France | 55 | F | 42 | Yes | Barrett’s esophagus | - | Not | T2DM, hypertension, dyslipidemia, arthritis |
Sista 201821 | Italy | 45 | M | 42.7 | - | - | - | - | |
Seki 201822 | Japan | 64 | F | 35.3 | Yes | Chronic atrophic gastritis | HP- | Not | T2DM |
Yamashita 201923 | Singapore | 42 | F | 35.8 | Not | - | HP- | Not | GERD, chronic gastritis |
Güzel 202024 | Cyprus | 60 | M | 38.5 | - | - | - | - | T2DM |
Muamar 202025 | Jordan | 26 | F | 52 | Yes | - | HP- | Not | - |
Aljarboo 202026 | Saudi Arabia | 58 | F | 52 | - | - | Hp+ | Not | GERD, hypertension, hypothyroidism, bronchial asthma, rheumatoid arthritis |
Genco 202027 | Italy | 54 | M | 43.1 | Yes | No abnormal finding | - | Yes | Hypertension, dyslipidemia, T2DM |
Genco 202027 | Italy | 21 | M | 75.6 | Yes | No abnormal finding | - | Not | OSA |
Genco 202027 | Italy | 39 | M | 46.3 | Yes | No abnormal finding | - | Yes | Hypertension |
Abbreviations: UGIE, upper gastrointestinal endoscopy; HP, Helicobacter pylori; OSA, obstructive sleep apnea; COPD, chronic obstructive pulmonary disease; GERD, gastroesophageal reflux disease; T1DM or T2DM, type 1 or type 2 diabetes mellitus.